How many clinical trials are tracked for Male hypogonadism?

19 trials are tracked, 8 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Male hypogonadism

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Male hypogonadism

19 trials tracked for Male hypogonadism: 14 in phase 3 or 4 and 8 with published results. The most-cited published study has 81 citations.

19Trials tracked

14Phase 3 & 4

0Recruiting

8With published results

Phase distribution

Phase 4 4 Phase 3 10 Phase 2 4 Other / NA 1

Phase 3 Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Completed · 81 cited
Phase 3 Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men Completed · 28 cited
Phase 3 Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). Completed · 17 cited
Phase 3 Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Completed · 14 cited
Phase 3 Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Completed · 14 cited
Phase 4 A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections Completed · 8 cited

Show 13 more trials

Phase 3 Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men Completed · 4 cited
Phase 3 Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men Completed · 4 cited
Phase 4 Subcutaneous vs. Intramuscular Testosterone Completed
Phase 4 Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters Completed
Phase 4 A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism Completed
Phase 3 Safety and Efficacy Trial of Testosterone Undecanoate Completed
Phase 3 Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) Completed
Phase 3 Time to Eugonadal Range, Time to Steady State and Drying Time Completed
Phase 2 Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function Completed
Phase 2 Pharmacokinetic Study to Determine Time to Steady-state Completed
Phase 2 5-Alpha Reductase and Anabolic Effects of Testosterone Completed
Phase 2 Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Completed
N/A Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.